rebel Financial rebel Financial
← All Posts
4502

Takeda Pharmaceutical Company Limited

June 25, 2026 • Author: Phil Ratcliff • 4502
Item Proposal Vote
1 Proposal No.1: Appropriation of Surplus ✓ For
2 Proposal No.2: Election of Eight (8) Directors who are not Audit and Supervisory Committee Members
2.1 Julie Kim Withhold
2.2 Milano Furuta Withhold
2.3 Andrew Plump Withhold
2.4 Masami Iijima ✓ For
2.5 Steven Gillis ✓ For
2.6 John Maraganore ✓ For
2.7 Miki Tsusaka ✓ For
2.8 Paul Stoffels ✓ For
3 Proposal No.3: Election of Three (3) Directors who are Audit and Supervisory Committee Members
3.1 Kimberly A. Reed ✓ For
3.2 Bruce Broussard ✓ For
3.3 Koichiro Kimura ✓ For
4 Proposal No.4: Election of One (1) Substitute Director who is an Audit and Supervisory Committee Member ✓ For
5 Proposal No.5: Payment of Bonuses to Directors who are not Audit and Supervisory Committee Members ✓ For
Attachments
📄
TKPYY_PROXY_STATEMENT.pdf 2.1 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.